Drug delivery to the back of the eye;Liberación de fármacos en el segmento posterior del ojo

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 82, Issue 11, 2007, Pages 669-670

  Kompella, U B ^a  

^a Universidad del Centro Médico de Nebraska   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ANTIVIRUS AGENT; APTAMER; EYE DROPS; FOMIVIRSEN; NANOPARTICLE; NUCLEOTIDE; PEGAPTANIB; VASCULOTROPIN A;

DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; EDITORIAL; EYE DISEASE; GLAUCOMA; HUMAN; INJECTION; PHASE 3 CLINICAL TRIAL; RETINA DISEASE; RETINA MACULA DEGENERATION;

ANTIVIRAL AGENTS; APTAMERS, NUCLEOTIDE; CLINICAL TRIALS, PHASE III AS TOPIC; DRUG ADMINISTRATION ROUTES; DRUG DELIVERY SYSTEMS; EYE DISEASES; GLAUCOMA; HUMANS; INJECTIONS; MACULAR DEGENERATION; NANOPARTICLES; OLIGONUCLEOTIDES, ANTISENSE; OPHTHALMIC SOLUTIONS; RETINAL DISEASES; THIONUCLEOTIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38849087294     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (8)

1. Skoura A, Sanchez T, Claffey K, Mandala SM, Proia RL, Hla T. Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J Clin Invest 2007; 117: 2506-2516.
2. Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A, et al. Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci U S A 2007; 104: 13444-13449.
3. Raghava S, Hammond M, Kompella UB. Periocular routes for retinal drug delivery. Expert Opin Drug Deliv 2004; 1: 99-114.
4. Amrite AC, Kompella UB. Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration. J Pharm Pharmacol 2005; 57: 1555-1563.
5. Amrite AC, Ayalasomayajula SP, Cheruvu NP, Kompella UB. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage. Invest Ophthalmol Vis Sci 2006; 47: 1149-1160.
6. Marra M, Gukasyan HJ, Raghava S, Kompella UB. 2nd Ophthalmic Drug Development and Delivery Summit. Expert Opin Drug Deliv 2007; 4: 77-85.
7. Mo Y, Barnett ME, Takemoto D, Davidson H, Kompella UB. Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene. Mol Vis 2007; 13: 746-757.
8. Kompella UB, Sundaram S, Raghava S, Escobar ER. Luteinizing hormone-releasing hormone agonist and transferrin functionalizations enhance nanoparticle delivery in a novel bovine ex vivo eye model. Mol Vis 2006; 12: 1185-1198.